Claims for Patent: 8,252,929
✉ Email this page to a colleague
Summary for Patent: 8,252,929
| Title: | 8-carboxamido-2,6-methano-3-benzazocines |
| Abstract: | 8-Substituted-2,6-methano-3-benzazocines of general structure I in which A is —CH2—OH, —CH2NH2, —NHSO2CH3, and Y is O, S or NOH are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications. 8-Carboxamides, thiocarboxamides, hydroxyamidines and formamides are preferred. |
| Inventor(s): | Mark P. Wentland |
| Assignee: | Rensselaer Polytechnic Institute |
| Application Number: | US13/103,599 |
| Patent Claims: |
1. A compound of formula: wherein A is Y is chosen from O and S; R1 is —NHR8; R2 and R2a are both hydrogen or taken together R2 and R2a are ═O; R3 is chosen from hydrogen, lower alkyl, alkenyl, aryl, heterocyclyl, benzyl and hydroxyalkyl; R4 is chosen from hydrogen, hydroxy, amino, lower alkoxy, C1-C20 alkyl and C1-C20 alkyl substituted with hydroxy or carbonyl; R5 is lower alkyl; R6 is lower alkyl; R7 is chosen from hydrogen and hydroxy; or together R4, R5, R6 and R7 may form from one to three rings, said rings having optional additional substitution; and R8 is hydrogen. 2. A compound according to claim 1 wherein A is chosen from the group consisting of: —CONH2 and —C(═S)NH2. 3. A 2,6-methano-3-benzazocine according to claim 1 wherein: R4 is chosen from hydrogen, hydroxy, lower alkoxy, C1-C20 alkyl and C1-C20 alkyl substituted with hydroxy or carbonyl; R5 is lower alkyl; R6 is lower alkyl; and R7 is hydrogen or hydroxy. 4. A 2,6-methano-3-benzazocine according to claim 3 wherein: R3 is chosen from hydrogen, cyclopropyl, cyclobutyl, phenyl, vinyl, dimethylvinyl, hydroxycyclopropyl, furanyl, and tetrahydrofuranyl; R4 is chosen from hydrogen and 3-oxo-5-cyclopentyl-1-pentanyl; R5 is methyl; and R6 is methyl or ethyl. 5. A morphinan according to claim 1 wherein together R5, R6 and R7 form two rings, said morphinan having the structure: wherein R4 is hydrogen, hydroxy, amino or lower alkoxy; R9 is hydrogen or lower alkyl; R10 is chosen from hydrogen, lower alkyl and hydroxy(lower alkyl); or together, R9 and R10 form a spiro-fused carbocycle of 5 to 10 carbons; R11 is hydrogen; R12 is chosen from hydroxy, lower alkoxy —NH2, —N(CH2CH2Cl)2, and —NHC(O)CH═CHCOOCH3; or together, R11 and R12 form a carbonyl or a vinyl substituent; or together, R4 and R11 form a sixth ring. 6. A morphinan according to claim 5, wherein R4 and R11 form a sixth ring, of formula 7. A morphinan according to claim 6 wherein R9 is hydrogen; R10 is hydroxy(lower alkyl); and R12 is lower alkoxy. 8. A morphinan according to claim 5, wherein R11 and R12 form a carbonyl substituent, of formula: 9. A morphinan according to claim 8 wherein R2 and R2a are both hydrogen; R4 is chosen from hydrogen, hydroxy, amino and lower alkoxy; and R9 and R10 are both hydrogen or together, R9 and R10 form a spiro-fused carbocycle of 5 to 10 carbons. 10. A morphinan according to claim 9 wherein R9 and R10 are both hydrogen. 11. A morphinan according to claim 5, wherein R11 and R12 form a vinyl substituent, of formula: 12. A morphinan according to claim 11 wherein R2 and R2a are both hydrogen; R4 is hydroxy; and R9 and R10 are both hydrogen. 13. A morphinan according to claim 5 wherein R2 and R2a are both hydrogen; R4 is hydroxy; R9 and R10 are both hydrogen; and R12 is chosen from: —NH2, —N(CH2CH2Cl)2, and —NHC(O)CH═CHCOOCH3. 14. A morphinan according to claim 1 wherein together R5, R6 and R7 form two rings, said morphinan having the structure: 15. A morphinan according to claim 5, wherein R4 and R11 form a sixth ring, of formula wherein R9 is hydrogen; R10 is hydroxy(lower alkyl); and R12 is lower alkoxy. 16. A 3-carboxamide substituted morphinan compound. 17. The morphinan compound of claim 16 having the formula: Wherein, R2 and R2a are both hydrogen; R3 is chosen from hydrogen, lower alkyl, alkenyl, aryl, heterocyclyl, benzyl and hydroxyalkyl; R4 hydroxyl; and, R9 and R10 are both hydrogen. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
